NasdaqGS - Delayed Quote USD

Lexicon Pharmaceuticals, Inc. (LXRX)

1.5400 -0.0600 (-3.75%)
At close: April 25 at 4:00 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
229,429.0000
194,299.0000
136,909.0000
203,788.0000
Total Liabilities Net Minority Interest
136,319.0000
77,175.0000
23,314.0000
47,417.0000
Total Equity Gross Minority Interest
93,110.0000
117,124.0000
113,595.0000
156,371.0000
Total Capitalization
192,618.0000
165,703.0000
113,595.0000
156,371.0000
Common Stock Equity
93,110.0000
117,124.0000
113,595.0000
156,371.0000
Capital Lease Obligations
6,556.0000
6,715.0000
2,279.0000
1,164.0000
Net Tangible Assets
48,567.0000
72,581.0000
69,052.0000
111,828.0000
Working Capital
145,001.0000
117,694.0000
66,797.0000
110,913.0000
Invested Capital
192,618.0000
165,703.0000
113,595.0000
168,017.0000
Tangible Book Value
48,567.0000
72,581.0000
69,052.0000
111,828.0000
Total Debt
106,064.0000
55,294.0000
2,279.0000
12,810.0000
Net Debt
77,043.0000
2,234.0000
--
--
Share Issued
245,792.6680
189,214.0000
150,082.0000
142,289.0000
Ordinary Shares Number
244,924.6950
188,726.0000
148,917.0000
141,496.0000
Treasury Shares Number
867.9730
488.0000
1,165.0000
793.0000
12/31/2020 - 4/7/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers